Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures
9 affiliations
- 1Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Australia
- 2School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Australia
- 3Impact and Evaluation, Hunter Medical Research Institute, Locked Bag 1000, New Lambton Heights, Newcastle, NSW 2305, Australia
- 4School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW 2308, Australia
- 5Infection Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW 2308, Australia
- 6Breathing and Lung Health Research Program, Hunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia
- 7Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW 2305, Australia
- 8School of Translational Medicine, Monash University, Melbourne, VIC 3800, Australia
- 9Respiratory Medicine, Alfred Hospital, Melbourne, VIC 3004, Australia
Abstract
Increasing evidence suggests that acquired dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel occurs as a result of cigarette smoke exposure in chronic obstructive pulmonary disease (COPD). CFTR-targeted therapies were developed to treat genetic CFTR defects in cystic fibrosis, but they have not demonstrated consistent clinical efficacy in small trials of patients with COPD. Here, we aimed to characterize CFTR and other ion channel activity and ciliation in primary bronchial epithelial cells (pBECs) from COPD donors compared with healthy controls, and to determine the extent to which CFTR dysfunction can be rescued by clinically relevant CFTR modulators. Air–liquid interface (ALI) cultures generated from conditionally reprogrammed (CR) primary bronchial epithelial cells (pBECs) obtained from healthy controls (n = 7) and COPD donors (n = 7) were assessed for transepithelial electrical resistance, immunofluorescence, cilia activity, ion channel function and expression of cell-type-associated markers at the transcript level. COPD cultures exhibited reduced ciliated area, accompanied by significantly decreased forskolin/IBMX-stimulated CFTR-mediated anion transport and ATP-induced calcium-activated chloride currents compared with healthy-control cultures, despite comparable CFTR mRNA expression. Treatment with CFTR potentiators (VX-770, GLPG1837 and icenticaftor) resulted in modest and highly variable functional responses, with no statistically significant improvement compared with vehicle-treated controls. CFTR function was not significantly associated with cumulative smoking exposure (pack-years) in this cohort, suggesting that smoking burden alone may not account for the observed inter-individual variability in acquired CFTR dysfunction. Collectively, these findings demonstrate abnormalities in ion transport and ciliation in the COPD airway epithelium consistent with an acquired CFTR dysfunction phenotype, but indicate that these abnormalities are not readily reversed by the tested CFTR potentiators. These results highlight differences between genetic and acquired CFTR dysfunction and underscore the need for alternative or combinatorial therapeutic strategies targeting epithelial dysfunction in COPD.
Related
- Glymphatic Dysfunction Across Neurological Disorders: Links to Neurodegeneration, Inflammaging, Gut–Brain Signaling, and Physiological Modulators
- Adaptive Cellular Responsiveness to Electrical Stimulation at the Skin‐Electrode Interface
- Peripheral muscle dysfunction persists in the era of highly effective CFTR modulators in cystic fibrosis
- Comparative assessment of the cytotoxicity of Nrf2-dependent signaling pathway modulators: the role of hormetic protective effect in Parkinson’s disease modeling in vitro
- Inter-vessel heterogeneity in coronary microvascular dysfunction: A three-vessel physiological assessment
BibTeX
@article{awatade2026assessment,
title = {{Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures}},
author = {Nikhil T. Awatade and Kurtis F. Budden and Prabuddha S. Pathinayake and Andrew T. Reid and Kristy S. Nichol and Peter A. B. Wark},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27198803},
url = {https://www.mdpi.com/1422-0067/27/19/8803},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures
AU - Nikhil T. Awatade
AU - Kurtis F. Budden
AU - Prabuddha S. Pathinayake
AU - Andrew T. Reid
AU - Kristy S. Nichol
AU - Peter A. B. Wark
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27198803
UR - https://www.mdpi.com/1422-0067/27/19/8803
AB - Increasing evidence suggests that acquired dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel occurs as a result of cigarette smoke exposure in chronic obstructive pulmonary disease (COPD). CFTR-targeted therapies were developed to treat genetic CFTR defects in cystic fibrosis, but they have not demonstrated consistent clinical efficacy in small trials of patients with COPD. Here, we aimed to characterize CFTR and other ion channel activity and ciliation in primary bronchial epithelial cells (pBECs) from COPD donors compared with healthy controls, and to determine the extent to which CFTR dysfunction can be rescued by clinically relevant CFTR modulators. Air–liquid interface (ALI) cultures generated from conditionally reprogrammed (CR) primary bronchial epithelial cells (pBECs) obtained from healthy controls (n = 7) and COPD donors (n = 7) were assessed for transepithelial electrical resistance, immunofluorescence, cilia activity, ion channel function and expression of cell-type-associated markers at the transcript level. COPD cultures exhibited reduced ciliated area, accompanied by significantly decreased forskolin/IBMX-stimulated CFTR-mediated anion transport and ATP-induced calcium-activated chloride currents compared with healthy-control cultures, despite comparable CFTR mRNA expression. Treatment with CFTR potentiators (VX-770, GLPG1837 and icenticaftor) resulted in modest and highly variable functional responses, with no statistically significant improvement compared with vehicle-treated controls. CFTR function was not significantly associated with cumulative smoking exposure (pack-years) in this cohort, suggesting that smoking burden alone may not account for the observed inter-individual variability in acquired CFTR dysfunction. Collectively, these findings demonstrate abnormalities in ion transport and ciliation in the COPD airway epithelium consistent with an acquired CFTR dysfunction phenotype, but indicate that these abnormalities are not readily reversed by the tested CFTR potentiators. These results highlight differences between genetic and acquired CFTR dysfunction and underscore the need for alternative or combinatorial therapeutic strategies targeting epithelial dysfunction in COPD.
SN - 1422-0067
ER -